Enzymotec Ltd. Reports Second Quarter 2014 Unaudited Financial Results
August 05, 2014 07:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported financial...
Enzymotec Ltd. to Participate in the Canaccord Genuity 34th Annual Growth Conference
July 31, 2014 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 31, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today...
Enzymotec Ltd. to Report Second Quarter Fiscal Year 2014 Financial Results
July 24, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 24, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that it will...
Enzymotec Ltd. Announces Publication of Clinical Study Results on Crying Reduction Following Usage of INFAT(R) in Infants
July 07, 2014 08:38 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, July 7, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today on publication...
Enzymotec Ltd. Reports Commercial Introduction of Its Innovative Omega PC(TM) Advanced Fish Oil Product
June 23, 2014 08:47 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, June 23, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today the launch of...
Enzymotec Ltd. to Present New Findings Regarding Positive Effects of INFAT(R) on Chinese Babies Stool and Behavior
June 05, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, June 5, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that results...
Enzymotec Ltd. to Participate in the Jefferies 2014 Global Healthcare Conference
May 23, 2014 08:43 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, May 23, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today...
Enzymotec Ltd. Announces an Extraordinary General Meeting of Shareholders to Approve Its Compensation Policy
May 20, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, May 20, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), today announced that it will hold an Extraordinary General Meeting of Shareholders on Thursday,...
Enzymotec Reports a Request for Arbitration by AAK
May 15, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, May 15, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, reports that...
Enzymotec Ltd. Reports First Quarter 2014 Unaudited Financial Results
May 14, 2014 07:30 ET
|
Enzymotec Ltd.
Net Revenues Increased 29% to $17.9 Million
Net Income Increased 118% to $5.1 Million, or $0.22 Per Share
(Quarterly Non-GAAP Net Income Increased 135% to $5.6 Million, or $0.24 Per...